| 000 | 01622 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518020809.0 | ||
| 264 | 0 | _c20190607 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2515-4184 | ||
| 024 | 7 |
_a10.1039/c8mo00190a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoulangé, Claire L | |
| 245 | 0 | 0 |
_aNMR and MS urinary metabolic phenotyping in kidney diseases is fit-for-purpose in the presence of a protease inhibitor. _h[electronic resource] |
| 260 |
_bMolecular omics _c02 2019 |
||
| 300 |
_a39-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aDiscriminant Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranous _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xmetabolism |
| 650 | 0 | 4 | _aLeast-Squares Analysis |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPrincipal Component Analysis |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 700 | 1 | _aRood, Ilse M | |
| 700 | 1 | _aPosma, Joram M | |
| 700 | 1 | _aLindon, John C | |
| 700 | 1 | _aHolmes, Elaine | |
| 700 | 1 | _aWetzels, Jack F M | |
| 700 | 1 | _aDeegens, Jeroen K J | |
| 700 | 1 | _aKaluarachchi, Manuja R | |
| 773 | 0 |
_tMolecular omics _gvol. 15 _gno. 1 _gp. 39-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1039/c8mo00190a _zAvailable from publisher's website |
| 999 |
_c29283076 _d29283076 |
||